Enoxaparin is a cardiovascular drug used to prevent and treat deep vein thrombosis (DVT) and pulmonary embolism (PE). It is a low molecular weight heparin (LMWH) that works by preventing the formation of blood clots. Enoxaparin is administered by subcutaneous injection and is available in both generic and branded forms. It is often used in combination with other anticoagulants such as warfarin. Enoxaparin is also used to reduce the risk of stroke and heart attack in patients with acute coronary syndrome. Enoxaparin is a widely used drug in the cardiovascular market and is available in many countries around the world. It is often prescribed as a first-line treatment for DVT and PE, and is also used in the prevention and treatment of other cardiovascular conditions. Some companies in the Enoxaparin market include Sanofi, Pfizer, Bristol-Myers Squibb, and GlaxoSmithKline. Show Less Read more
ASK A QUESTION
We request your telephone number so we can contact you in the event we have difficulty reaching you via email. We aim to respond to all questions on the same business day.
